ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
Language dysfunction as a primary feature of cognitive decline in neurological populations.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Slow-4 cerebellar activity tracks MMSE language-related task performance across the Alzheimer's disease spectrum: a multi-metric resting-state fMRI study.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive decline is a common feature of neurologic conditions, with language functions often affected. Word finding difficulties are commonly reported to neurologists in clinic. Receptive language dysfunction (i.e., comprehension) tends to be more difficult to recognize for both the patient and the clinician. Subtle yet pervasive decrements in language may be a key feature (and potential driver) of pathological cognitive decline inherent to neurologic diseases involving a primary or secondary neurodegenerative process. While severe language impairment such as aphasia presenting in the context of stroke or dementia has been studied in detail, mild or insidious presentations remain relatively understudied. In this review, we evaluate neural substrates and clinical manifestations of language deficits noted in four neurologic populations: Alzheimer's disease (AD), stroke, multiple sclerosis (MS), and Parkinson's disease (PD). Despite differences in etiology and pathophysiology, these four neurologic populations each present with prominent language dysfunction. For each, we describe neuroanatomical substrates and networks underlying language dysfunction. We then describe current observations of language dysfunction in each population. We incorporate a discussion of emerging speech measurement tools employing machine learning (ML) and artificial intelligence (AI). Overall, we provide evidence to support a nascent hypothesis of language dysfunction as a potential driver of cognitive decline across neurologic populations with the aim of motivating novel research insights and informing clinical care.
Indexed as
Identifiers
40913642What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.